Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NVCR
Stock Latest News
Company Announcements
NovoCure Gains Approval for Optune Lua in Japan
3d ago
8K
NVCR
Premium
The Fly
Novocure announces Japan MHLW approval for Optune Lua
3d ago
NVCR
Premium
The Fly
Novocure announces coverage for Tumor Treating Fields therapy in Spain
24d ago
NVCR
Premium
The Fly
Novocure submits Tumor Treating Fields therapy premarket approval application
29d ago
NVCR
Premium
Company Announcements
NovoCure’s Pivotal Study on Optune® for Glioblastoma: A Market Game-Changer?
1M ago
NVCR
Premium
Company Announcements
Novocure’s Earnings Call: Clinical Successes & Cautious Optimism
2M ago
NVCR
Premium
Ratings
Positive Outlook for NovoCure: Strong Financial Performance and Promising Pipeline Developments
2M ago
NVCR
Premium
Company Announcements
Novocure Ltd. Reports Q2 2025 Financial Results
2M ago
NVCR
Premium
The Fly
Wells Fargo downgrades Novocure after ‘disappointing’ Q2
2M ago
NVCR
Premium
The Fly
Novocure downgraded to Equal Weight from Overweight at Wells Fargo
2M ago
NVCR
Premium
Ratings
NovoCure’s Strategic Growth and Market Expansion Drive Buy Rating
2M ago
NVCR
Premium
The Fly
Novocure reports Q2 EPS (36c), consensus (39c)
2M ago
NVCR
Premium
Pre-Earnings
NVCR Earnings this Week: How Will it Perform?
2M ago
NVCR
Premium
The Fly
Ladenburg starts Novocure with a Buy, sees ‘path to profitability’
2M ago
NVCR
Premium
The Fly
Novocure initiated with a Buy at Ladenburg
2M ago
NVCR
Premium
Ratings
Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer
3M ago
NVCR
Premium
The Fly
Novocure to present final secondary endpoint results from PANOVA-3 trial
3M ago
NVCR
Premium
The Fly
Novocure management to meet with Piper Sandler
3M ago
NVCR
Premium
Company Announcements
NovoCure Appoints New President at Annual Meeting
3M ago
8K
NVCR
Premium
The Fly
Novocure data support pancreatic cancer approval, says Wells Fargo
4M ago
NVCR
Premium
Company Announcements
NovoCure Announces Positive Phase 3 Trial Results
4M ago
8K
NVCR
Premium
Ratings
Positive Buy Rating for NovoCure Driven by Promising PANOVA-3 Trial Results in Pancreatic Cancer Treatment
4M ago
NVCR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
